Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Parkinson's drug
Research
Gain's clinical Parkinson's drug restores motor function in mice
The phase 1 drug for Parkinson’s disease that's associated with a common gene mutation restored motor function even after delay to treatment.
Helen Floersh
Feb 6, 2024 8:00am
Open science contest uses AI to ID hits for Parkinson’s
Jan 18, 2024 5:00am
Aptinyx dumps dementia drug, stops PTSD trial after phase 2 flop
Feb 28, 2023 6:15am
Qiagen to develop companion diagnostic for Parkinson's drug
Sep 16, 2022 11:53am
Addex scraps Parkinson's phase 3 over COVID-impacted enrollment
Jun 17, 2022 5:50am
Brain circuits could inspire new Parkinson's treatment: MIT
Jun 10, 2022 10:50am